Multiple Sclerosis

Loss of sense of smell predicts more severe multiple sclerosis.

The multiple sclerosis drug may become cheaper with Teva’s loss of exclusivity.

Biomarkers could provide a disease-free multiple sclerosis status.

An association is logical: nerve and eye tissue develop from the same cells.

The study was the largest of MS patients treated with rituximab to date.

Relapses in patients taking natlizumab affected their disabilities in the short term, but not over a longer period.

A study finds that massages may improve fatigue, pain symptoms in MS patients.

An MS diagnosis is depressing, but cognitive behavioral therapy helps.

Diagnosing pediatric MS: more accurate with test refinements.

Treating multiple sclerosis early pays off in higher patient incomes.

Multiple sclerosis: Eat like a cave-dweller and get symptom relief?

Multiple sclerosis patients appear to be less likely to get cancer, possibly because of drugs they take to modify the symptoms of MS.

People with multiple sclerosis tend to have sleep apnea, but not the usual kind, a study found.

Looking at post-mortem brain samples, researchers found that multiple sclerosis is associated with an abundance of bacteria and molecular diversity.

Between daily news and conferences around the United States and Europe, it was a busy year in multiple sclerosis research.

Researchers have been studying the potential multiple sclerosis drug ocrelizumab (Ocrevus/Genentech) for years. Results from those studies have been published in the New England Journal of Medicine (NEJM).

Finding neural stem cells in the brain’s meninges could lead to new therapies for multiple sclerosis patients.

Alemtuzumab was more beneficial to patients with relapsing remitting multiple sclerosis than subcutaneous interferon beta 1a in various measures of preexisting disability.

Physicians have long been concerned that patients with multiple sclerosis who get frequent brain scans accumulate deposits of the rare earth used as a contrast agent, gadolinium. German researchers found an alternative agent.

Patients with multiple sclerosis may have excess iron in their brains, a possible explanation for brain atrophy, the debilitating condition some develop. If so, the culprit is likely leaky red blood cells, a UK team reported.

The nonprofit, Institute for Clinical and Economic Review, is preparing a set of recommendations on best drugs for multiple sclerosis and is seeking public comment.

A signaling mechanism can turn T-cells into destroyers.

Cornell scientists said they created a chemical tool that uses ultraviolet light to track inflammation and even control it. Their hope is it might work to treat inflammatory diseases, perhaps even multiple sclerosis.

A research team has come up with a road map for physicians helping patients with multiple sclerosis feel less tired and lethargic. It's called the Berlin Treatment Algorithm.

New methods are needed to study whether diet changes really help in multiple sclerosis.

Patients with intermediate uveitis (IU) have a high likelihood of achieving good long-term visual outcomes, but should expect a long disease course and frequent complications

High-dose biotin may be an effective treatment for progressive multiple sclerosis, researchers in France found.

For many patients who are vitamin D deficient, there are oral supplements which can be found over the counter which can help bring their levels into the normal range. That and other steps can help play a role in lessening the risk of developing multiple sclerosis.

A study looking at pregnant women in Finland showed a potential connection between low levels of vitamin D and the development of multiple sclerosis.

Whether patients need to move to stronger medications, or find a more effective treatment, doctors need as much information as possible before making a decision on what course to follow.